ViroPharma Lied About Antibiotic Exclusivity, Investor Says
A shareholder on Wednesday filed a proposed class action against ViroPharma Inc. seeking damages for stock losses allegedly sustained after the company wrongly led investors to believe it had secured three...To view the full article, register now.
Already a subscriber? Click here to view full article